Oral Tablet -> Lionine T3


Lionine -T3

Pharmaceutical Name: Lionine -T3

Chemical Name: Liothyronine Sodium

Unit Available:100 Tablets.

Each tablet contain: 100 mcg.

Description

 

Liothyronine sodium is a synthetically manufactured prescription thyroid hormone. It specially consists of the L-isomer of the natural thyroid hormone triiodothyronine (T3).Thyroid hormones stimulate basal metabolic rate,and are involved with many cellular functions including protein, fat, and carbohydrate metabolism. Liothyronine sodium is used medically to treat hypothyroidism, a condition where the thyroid gland does not produce sufficient levels of thyroid hormone. Hypothyroidism is usually diagnosed with a serum hormone profile (T3,T4, & TSH),and may manifest itself with symptoms including loss of energy, lethargy, weight gain, hair loss, and changes in skin texture. T3 is the most active thyroid hormone in the body, and consequently Iiothyronine sodium is considered to be a more potent thyroid medication than levothyroxine sodium (T4).

 

Bodybuilders and athletes are attracted to liothyronirre sodium for its ability to increase metabolism and support the breakdown of body fat. Most often utilized during wfttest preparation or periods of ”cutting’l the drug is usually said to significantly aid in the loss of fat, often on higher levels of caloric intake than would normally be permissive of such fat loss. To this end, the drug is also commonly used in conjunction with other fat loss agents such as human growth hormone or beta agonists, Some users also ascribe an ability of thyroid hormones like liothyronine sodium to increase the anabolic effect of steroids. While in theory these drugs may support the greater utilization of protein and carbohydrates for muscle growth, they are not widely proven or accepted for this Purpose.

 

Structural Characteristics

 

Liothyronine sodium is a synthetic form of T3 thyroid hormone. It has the chemical designation l-tyrosine,o-(4-hydroxy-3-iodophenyl)-3,5-diiodo-,monosodium salt.

 

Dosage Recommanded

 

When used to treat mild hypothyroidismathe typical recommended starting dosage is 25 mcg daily. The daily dosage then may be increased by no more than 25 mcg every 1 to 2 weeks. The established maintenance dose is usually 25-75 mcg per day. Once a day administration of the full daily dose is usually recommended. Although liothyronine sodium is fast acting, its effects may persist in the body for several days after discontinuance. The usual protocol among bodybuilders and athletes taking liothyronine sodium to accelerate fat loss involves initiating its use with a dosage of 25 mcg per day. This dosage may be increased by 25 mcg every 4 to 7 days, usually reaching a maximum of no more than 75 mcg per day. As in a medical setting, the intent of this slow buildup is to help the body become adjust to the increasing thyroid hormone levels, and avoid sudden changes that may initiate side effects. Cycles of liothyronine sodium usually last no longer than 6 weeks, and administration of the drug should not be halted abruptly. Instead, it is discontinued in the same slow manner in which it was initiated. This usually entails reducing the dosage by 25 mcg every 4 to 7 days. This tapering is done so that the body has time to readjust its endogenous hormone production at the conclusion of therapy, and to avoid the onset of side effects.

 

Side Effects

 

Side effects are generally associated with overdosage, and may include headache, irritability, nervousness, sweating, irregular heartbeat, increased bowel motility, or menstrual irregularities. Overdosage may also induce shock, and may aggravate or trigger angina or congestive heart failure. Chronic overexposure to liothyronine sodium will produce symptoms normally associated with hyperthyroidism or the overproduction of natural thyroid hormones in the body. The occurrence of overexposure~linked side effects is normally cause to immediately reduce or discontinue therapy with liothyronine sodium. Acute massive overdose may be life threatening. 

 

 

 

Systematic name : sodium (2S)-2-amino-3- [4-(4-hydroxy-3-iodophenoxy)-3,5-diiodophenyl] propanoate